A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer glioblastoma spreads. In newly published research, they identify a potential treatment target to slow or even stop it. Glioblastoma is an aggressive form of cancer that affects 4 in 100,000 people, according to Brain Tumor Canada, with an average survival of 12 to 18 months.